Cellebrite's stock fell 6.36% in pre-market trading on Thursday following the release of its first-quarter 2026 financial results.
The digital intelligence company reported quarterly revenue of $128.301 million, slightly above analyst estimates of $126.8 million. Adjusted EBITDA also beat expectations, coming in at $30.617 million versus the $27.2 million estimate. However, the company's net income of $10.938 million significantly missed the Ibes estimate of $23.9 million, which appears to be the primary driver behind the stock's decline.
For the second quarter, Cellebrite provided an outlook for revenue between $130 million and $133 million, and adjusted EBITDA between $29 million and $31 million.
Comments